Community Clinical Oncology Program
Research Base Protocol Credit Assignment
Approved, Active, and Closed Protocols

Research Base Southwest Oncology Group (SWOG)
qry_Credit_Report_Output_HTML_SWOG
Protocol Number Type of Cancer or Study Intergroup Number Coordinating Center Study Status Closure Date Treatment Credit Cancer Control Credit Followup Credit Followup Years Credit Description
62933 Sarcoma 62933 EORTC CL 10/15/2000 1
0 0 EORTC is Coordinating Group
89803 Gastrointestinal C89803 CALGB CL 5/15/2001 1
0 0
ACOSOG-Z9000 Gastrointestinal ACOSOG-Z9000 CTSU CL 9/26/2003 1 0 0 0
ACOSOG-Z9001 Gastrointestinal ACOSOG-Z9001 CTSU CL 4/18/2007 1 0 0 0
AEWS0031 Sarcoma AEWS0031 COG CL 8/6/2005 1 0 0 0
BMTCTN-0102 Other
SWOG CL 3/30/2007 1 0.5 0 0 Cancer Control credit for QOL
BMTCTN-0401 Lymphomas Non-Hodgkin's
SWOG AC
1 0 0 0
C19807 Leukemia, Chronic C19807 CALGB CL 5/15/2001 1
0 0
C80002 Gastrointestinal CALGB-80002 CALGB CL 8/29/2003 1 0 0 0
C90003 Genitourinary CALGB-90003 CALGB CL 4/15/2004 1 0 0 0
C9581(S) Gastrointestinal
CALGB CL 5/31/2002 1.1 0 0 0 0.1 CREDIT FOR MARKER STUDY
C9732(S) Lung C9732 CALGB CL 7/13/2001 1
0 0
C9741(S) Breast C9741 CALGB CL 3/31/1999 1 0 0 0
CALGB-10404 Leukemia, Chronic CALGB-10404 CALGB AC
1 0 0 0
CALGB-19801 Leukemia, Acute CALGB-19801 CALGB CL 9/12/2001 1
0 0
CALGB-30102 Lung CALGB-30102 CALGB CL 12/28/2004 1 0.3 0 0 Cancer Control credit for QOL
CALGB-40101 Breast CALGB-40101 CALGB AC
1
0 0
CALGB-49907 Breast CALGB-49907 CALGB CL 12/29/2006 1 0.2 0 0 Assignment changed to 0.2 CC credits for sites and research base. Original assignment = 0.5 cc credit for QOL to the CALGB Research Base only.
CALGB-80101 Gastric CALGB-80101 CALGB AC
1 0 0 0
CALGB-9687 Genitourinary CALGB-9687 CALGB CL 2/15/2003 1
0 0
CALGB-9710 Leukemia, Acute CALGB-9170 CALGB CL 3/29/2005 1
0 0
E1199 Breast E1199 ECOG CL 1/8/2002 1
0 0
E1295(S) Gastrointestinal E1295 ECOG CL 2/15/1999 0 0.5 0 0
E1395(S) Head and Neck E1395 ECOG CL 1/12/2000 1
0 0
E1695 Melanoma E1695 ECOG CL 10/15/1999 0.1
0 0
E1697 Melanoma E1697 ECOG AC
1 0.5 0 0 0.5 Cancer Control credit is for QOL
E1899 Genitourinary E1899 ECOG CL 12/28/2004 1 0 0 0
E1905 Leukemia, Acute E1905 ECOG AC
1 0 0 0
E1A02 Other E1A02 ECOG CL 4/26/2007 1 0 0 0
E1A95(S) Multiple Myeloma EA195 ECOG CL 6/15/1999 1 0 0 0 INTERGROUP W/ECOG;SWOG;CALGB & NCIC
E1D96 Immunosuppressive Disorders E1D96 ECOG CL 12/15/2000 1 0.5 0 0 0.5 CC Credit for QOL
E2100 Breast E2100 ECOG CL 5/26/2004 1 0 0 0 No Cancer Control credit for QOL
E2197(S) Breast E2197 ECOG CL 1/21/2000 1 0 0 0
E2496(S) Lymphomas, Hodgkin's Disease E2496 ECOG CL 6/15/2006 1 0 0 0
E2697 Melanoma E2697 ECOG CL 4/18/2002 0.1
0 0 Correlative Study
E2997 Leukemia, Chronic E2997 ECOG CL 3/19/2004 1 0 0 0
E2998 Leukemia, Acute E2998 ECOG CL 10/1/2001 1
0 0
E3695(S) Melanoma E3695 ECOG CL 4/17/2002 1 0 0 0
E4397 Brain E4397 ECOG CL 11/15/2003 1
0 0
E4494 Lymphomas Non-Hodgkin's E4494 ECOG CL 7/12/2001 1
0 0
E4697 Melanoma E4697 ECOG CL 10/31/2006 1
0 0
E5597 Intervention Study E5597
Active

1 0.3

E8892(S) Genitourinary E8892 ECOG CL 5/27/1998 1 0.5 0 0 INTERGROUP STUDY WITH ECOG;SWOG & CALGB CC CREDIT FOR QOL
E8897 Genitourinary E8897 ECOG CL 12/28/2004 0.1
0 0
EORTC-30904 Other EORTC-30904
CL 1/13/2003 1
0 0
EORTC-30987 Genitourinary EORTC-30987 SWOG CL 6/1/2004 1
0 0
G0137 Gynecologic GOG-137A GOG CL 1/20/2003 0.5 0.5 0 0 0.5 RX CREDIT & 0.5 CC CREDIT
GOG-0182 Gynecologic GOG-0182 GOG CL 9/1/2004 1
0 0
GOG-164(S) Gynecologic GOG-164 GOG CL 6/1/1999 1 0 0 0
GOG-175 Gynecologic GOG-175 GOG CL 8/15/2003 1 0 0 0
IBCSG-24-02 Breast IBCSG-24-02 CTSU AC
1 0.5 0 0 0.5 Cancer Control credit for QOL
IBCSG-25-02 Breast IBCSG-25-02 CTSU CL 11/30/2007 1 0.5 0 0 0.5 Cancer Control credit for QOL
JBR10(S) Lung Non-Small Cell JBR10 NCIC CL 4/30/2001 1.1 0 0 0 INCLUDES COMPANION TUMOR MARKER EVALUATION
JPR.7 Genitourinary JPR.7 NCIC CL 11/30/2005 1 0.5 0 0 0.5 CC CREDIT FOR QOL
JPR3 Genitourinary T94-0110 NCIC CL 8/31/2005 1
0 0
MA.17(S) Breast MA.17 NCIC CL 8/31/2002 1 0.5 0 0 0.5 CC CREDIT FOR QOL
MDA-3410 Genitourinary MDA-3410 MDA AC
1 0 0 0
N0426 Lung Non-Small Cell N0426 NCCTG CL 2/23/2007 1 0 0 0
N9741 Gastrointestinal N9741 NCCTG CL 7/18/2002 1 0.3 0 0 0.3 CC Credit for QOL
N9831 Breast N9831 NCCTG CL 4/30/2005 1
0 0
N9841 Gastrointestinal N9841 NCCTG CL 12/17/2003 1 0.5 0 0 CC Credit is for QOL component
NCIC-BR.19 Lung Non-Small Cell NCIC-BR.19 CTSU CL 4/22/2005 1 0 0 0
NCIC-MA.20 Breast NCIC-MA.20 CTSU CL 2/2/2007 1 0 0 0 No Credit for QOL since CTSU sites (including CCOPs) will not participate in this component of the study
NCIC-MA.21 Breast NCIC-MA.21 CTSU CL 4/29/2005 1 0 0 0 No Credit for QOL since CTSU sites (including CCOPs) will not participate in this component of the trial
NCIC-MA.27 Breast NCIC-MA.27 CTSU AC
1 0 0 0
NCIC-PR.11 Genitourinary NCIC-PR.11 CALGB AC
1 0.5 0 0 0.5 Cancer Control credit for QOL component of trial
NSABP B-30 Breast NSABP-B-30 NSABP CL 3/31/2004 1 0.5 0 0 0.5 Cancer Control credit for QOL
NSABP B-33 Breast NSABP-B-33 NSABP CL 10/9/2003 1 0.5 0 0 0.5 Cancer Control credit for QOL
NSABP B-34 Breast NSABP B-34 NSABP CL 3/31/2004 1.2 0 0 0
NSABP B-35 Breast NSABP-B-35 NSABP CL 6/15/2006 1.1 0.3 0 0 0.3 Cancer Control credit for QOL
R0214 Lung Non-Small Cell RTOG-0214 RTOG CL 8/30/2007 1 0.5 0 0 0.5 Cancer Control credit for QOL
R9704(S) Pancreatic R9704 RTOG CL 7/26/2002 1
0 0
R9804 Breast RTOG 98-04 RTOG CL 7/14/2006 1 0 0 0
R9811(S) Gastrointestinal INT-0157 RTOG CL 6/27/2005 1 0 0 0
R9813 Brain RTOG 98-13 RTOG CL 3/30/2007 1 0 0 0 No CC Credit for the QOL - only assessing toxicity differences
RTOG 98-02(S) CNS, Pituitary RTOG 98-02 RTOG CL 6/27/2002 1 0 0 0
RTOG-0212 Lung RTOG-0212 RTOG CL 3/3/2008 1 0.5 0 0 0.5 Cancer Control credit for QOL
RTOG-0412-SWOG-S0332 Lung Non-Small Cell RTOG-0412-SWOG-S0332 RTOG CL 12/1/2006 1 0.5 0 0 0.5 Cancer Control credit for QOL
RTOG-P-0014 Genitourinary RTOG-P-0014 RTOG CL 2/4/2005 1 0 0 0
S0000 Intervention Study S0000
Closed 6/24/2004
1 0.3

S0000A Intervention Study

Active
0 0

This study is funded by NIA and therefore no credit is assigned
S0000B Descriptive

Active

0

This ancillary study is funded by the NEI therefore no credit is assigned.
S0000C


Closed 5/1/2007
0

This ancillary study is funded by NHLBI therefore no credit is assigned
S0001 Brain
SWOG CL 11/15/2005 1
0 0
S0002 Intervention Study S0002
Closed 1/1/2004
1

Credit Assignment increased from original 0.7 CC Credit upto 1.0 CC Credit
S0003 Lung Non-Small Cell S0003 SWOG CL 11/15/2002 1
0 0
S0004 Other
SWOG CL 4/1/2002 1
0 0
S0007 Head and Neck
SWOG CL 3/31/2004 1
0 0
S0008 Melanoma S0008 SWOG CL 11/15/2007 1
0 0
S0009 Gynecologic
SWOG CL 2/1/2006 1
0 0
S0010 Leukemia, Acute
SWOG CL 11/1/2003 1
0 0
S0011 Head and Neck
SWOG CL 7/1/2006 1 0 0 0
S0012 Breast S0012 SWOG CL 12/1/2005 1
0 0
S0013 Gynecologic
SWOG CL 11/15/2003 0.2 0 0 0
S0014 Lymphomas Non-Hodgkin's
SWOG CL 1/15/2002 1
0 0
S0016 Lymphomas S0016 SWOG AC
1 0 0 0
S0019 Lymphomas
SWOG CL 12/15/2001 1
0 0
S0020 Other S0020 SWOG CL 5/15/2003 1
0 0
S0022 Lung Non-Small Cell
SWOG CL 2/1/2003 1
0 0
S0023 Lung Non-Small Cell S0023 SWOG CL 4/15/2005 1
0 0
S0025 Gynecologic
SWOG CL 3/31/2004 1
0 0
S0026 Melanoma
SWOG CL 5/1/2003 1 0 0 0
S0027 Lung Non-Small Cell
SWOG CL 7/1/2003 0.5 0.5 0 0 Credit Assignment Changed from 1.0 RX to 0.5 RX and 0.5 Cancer Control (CC) for the QOL component.
S0028 Genitourinary
SWOG CL 12/15/2006 1 0.2 0 0 0.2 Cancer Control credit for QOL feasibility
S0029 Breast
SWOG CL 6/15/2005 1 0.2 0 0 0.2 Cancer Control credit for QOL feasibility
S0030 Gastrointestinal
SWOG CL 2/1/2005 1 0.2 0 0 0.2 Cancer Control Credit for QOL feasibility
S0031 Genitourinary
SWOG CL 10/15/2002 1
0 0
S0032 Genitourinary
SWOG CL 6/1/2005 1
0 0
S0033 Other S0033 SWOG CL 9/1/2001 1
0 0
S0101 Gastrointestinal
SWOG CL